Work

Preclinical modeling of the AKT inhibitor MK2206 and topotecan in small cell lung cancer (SCLC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e17537

Authors: William S. Holland, Danielle C. Chinn, Primo Lara, David R. Gandara, Philip C Mack, Karen Kelly

Institutions: University of California, Davis, UC Davis Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2966122802

Cites:

Cited by: 1

Related to: 10